Skip to main content
. 2017 Jun;17(3):220–232. doi: 10.7861/clinmedicine.17-3-220

Fig 3.

Fig 3.

Emerging antibody technologies. A – derivatives of classical mAbs: scFv, Fab, and F-Cab antibody formats; B – engineered bi-specific mAbs: structure and mechanism of a bi-specific T-cell engaging (BiTE) antibody; C – novel mAb frameworks: unique structure of camelid antibodies. mAb = monoclonal antibody